상세 보기

Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.

Ahn, Myung-Ju;
Han, Ji-Youn;
Kim, Sang-We;
Lee, Ki Hyeong;
Kim, Dong-Wan;
... Lee, Jong-Seok;
... Shin, Sang Won;
외 13명

제목: Lazertinib, a 3rd generation EGFR-TKI, in patients with EGFR-TKI resistant NSCLC: Updated results of phase I/II Study.

저자: Ahn, Myung-Ju; Han, Ji-Youn; Kim, Sang-We; Lee, Ki Hyeong; Kim, Dong-Wan; Lee, Yun-Gyoo; Cho, Eun Kyung; Lee, Gyeong-won; Lee, Jong-Seok; Kim, Joo-Hang; Kim, Jin-Soo; Min, Young Joo; Lee, Sung Sook; Shin, Sang Won; Kim, HyeRyun; Hong, Min Hee; Ahn, Jin Seok; Lee, Seoung Oh; Kim, Sohee; Cho, Byoung Chul

DOI: 10.1200/JCO.2019.37.15_suppl.9037

발행일: 2019-05-20

학회명: 2019 ASCO Annual Meeting

개최지: Chicago, IL

개최국가: 미국

학회 개최일: 2019-05-31 ~ 2019-06-04

언어: ENG